Arrowhead Pharmaceuticals, Inc. (ARWR)

64.34 +0.65 (+1.02%) USD  |  NASDAQ  |  Feb 18, 16:00
64.01 -0.33 (-0.51%) After-Hours: 20:00
More

Arrowhead Pharmaceuticals Operating Income (Quarterly)

Operating Income (Quarterly) Chart

View Operating Income (Quarterly) for ARWR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Quarterly) Range, Past 5 Years

View Operating Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Quarterly) Benchmarks

View Operating Income (Quarterly) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. Upgrade
Sanofi --
Eli Lilly & Co. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade